RESAQUIT

This brand name is authorized in Ecuador.

Active ingredients

The drug RESAQUIT contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII R16CO5Y76E - ASPIRIN
 

Acetylsalicylic acid combines significant advantages such as strong anti-pyretic, analgesic and anti-inflammatory action, that is the measure of comparison with all the newer NSAIDs.

 
Read more about Acetylsalicylic acid
2
UNII 362O9ITL9D - ACETAMINOPHEN
 

Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain.

 
Read more about Paracetamol
3
UNII 3G6A5W338E - CAFFEINE
 

Caffeine is structurally related to the methylxanthines theophylline and theobromine. Caffeine’s main action is as a CNS stimulant.

 
Read more about Caffeine
4
UNII 5QB0T2IUN0 - ALUMINUM HYDROXIDE
 

Aluminium hydroxide is a slow-acting antacid. It is used to provide symptomatic relief in gastric hyperacidity. In addition, the antipeptic and demulcent activity of aluminium hydroxide helps to protect inflamed gastric mucosa against further irritation by gastric secretions.

 
Read more about Aluminium hydroxide
5
UNII NBZ3QY004S - MAGNESIUM HYDROXIDE
 

Magnesium hydroxide is practically insoluble in water and solution is not effected until the hydroxide reacts with hydrochloric acid in the stomach to form magnesium chloride. Its neutralising action is almost equal to that of sodium bicarbonate. When the dose is in excess of that required to neutralise the acid the intragastric pH may reach pH 8 or 9. Acid rebound following magnesium hydroxide is clinically insignificant. Magnesium hydroxide has an indirect cathartic effect resulting from water retention in the intestinal lumen.

 
Read more about Magnesium hydroxide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N02BA Salicylic acid and derivatives N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics
Discover more medicines within N02BA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 423-MEE-0814

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.